Proto Labs, Inc.

Valuation Analysis

About the Company

Proto Labs, Inc., together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. It offers manufacturing services, such as molding, computer numerical control machining, 3D printing, and sheet metal to developers, engineers, and supply chain teams. The company was incorporated in 1999 and is headquartered in Maple Plain, Minnesota.

Proto Labs, Inc. Stock at a Glance

Proto Labs, Inc. (PRLB) is currently trading at $78.94 with a market capitalization of $1.9B. The trailing P/E ratio stands at 74.47x, with a forward P/E of 35.76x. The 52-week range spans from $37.91 to $79.48; the current price is 0.7% below the yearly high. Year-over-year revenue growth stands at +10.4%. The net profit margin stands at 4.71%.

💰 Dividend

Proto Labs, Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Analyst Rating

3 analysts rate Proto Labs, Inc. (PRLB) on consensus: Buy. The average price target is $75.67, implying -4.15% from the current price. Analyst price targets range from $70.00 to $82.00.

Proto Labs, Inc.: The Investment Case in Detail

Proto Labs, Inc. (PRLB) operates in the Industrials — specifically Metal Fabrication — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Revenue is growing at a healthy 10.4% pace year-over-year, suggesting the business model continues to find new customers and pricing power. Earnings growth of 121.3% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base.

The Bear Case

With a net margin of just 4.71%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss. A trailing P/E above 50 combined with revenue growth below 20% is a dangerous combination — the market is paying a steep growth multiple for what is, by the data, only moderately fast expansion. Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.

Valuation in Context

With a PEG ratio of 0.86, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity. The EV/EBITDA multiple of 26.24x reflects rich expectations — historically, multiples at this level have proven hard to maintain for more than a few quarters.

What to Watch Next

• The forward P/E of 35.76x is meaningfully below the trailing 74.47x — analysts expect earnings to step up; the next earnings release is the test.
• The share is trading at 98.7% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Risk Profile

The data points to market-like volatility.

Trading Data

Related Stocks in the Same Sector

Where can I buy Proto Labs, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.